Business Context and Reporting Period
Mira Pharmaceuticals, Inc. (MIRA), a Florida corporation listed on the Nasdaq Capital Market, filed this Form 8-K on July 27, 2026. The filing addresses a regulatory notice regarding the company's compliance with Nasdaq listing standards.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The only quantitative metric disclosed is the stock price performance triggering the notice: the closing bid price of the Common Stock was below $1.00 per share for 30 consecutive business days ended July 24, 2026.
Material Changes
The material change reported is the receipt of a letter from the Nasdaq Listing Qualifications Staff indicating the company no longer meets the Minimum Bid Price Requirement (Rule 5550(a)(2)). This deficiency is based on the stock's closing bid price remaining below $1.00 for the specified 30-day period.
Guidance, Outlook, and Risks
- Compliance Period: The company has been granted an initial 180-day compliance period, ending January 25, 2027, to regain compliance.
- Remediation Requirements: To regain compliance, the closing bid price must be at least $1.00 per share for a minimum of ten consecutive business days within the 180-day window.
- Future Options: If compliance is not achieved, the company may seek a second 180-day period if it meets other listing standards, potentially by effecting a reverse stock split.
- Risks: There is no assurance the company will regain compliance. Failure to do so could result in delisting. An appeal to a Nasdaq Hearings Panel is possible but not guaranteed to be successful.
- Management Intent: Management intends to actively monitor the stock price and consider available options to resolve the deficiency.
Investor Verification Checklist
- Verify the current closing bid price of MIRA stock to assess proximity to the $1.00 threshold.
- Monitor the company's stock price for ten consecutive days above $1.00 to confirm compliance.
- Review future filings for announcements regarding a potential reverse stock split.
- Check for any subsequent Nasdaq communications regarding the extension of the compliance period or delisting notices.